found glp 1 GLP-1 meds slow cancer progression in new Cleveland Clinic study | Cleveland Clinic posted on the topic Health's new survey of current,

For a deeper look at how semaglutide, a GLP-1 receptor agonist, compares to tirzepatide, a dual GLP-1 and GIP receptor agonist, read our comparison guide on semaglutide vs

This protective effect persisted in Glp1r Tie2/ mice, suggesting that the expression of immune cell or endothelial cell GLP-1Rs is not essential for this action

Pancreatic -cell mass is significantly reduced by more than 50% in patients with T2DM, with lesser reductions already occurring in the prediabetes state (124)

The available GLP-1RAs have undergone various modifications to extend the half-life and allow once daily or once weekly dosing

Tirzepatide (Mounjaro, Zepbound) works through a related but distinct mechanism as a dual GIP/GLP-1 receptor agonist